PsyBio Therapeutics EPS
Qual é o EPS de PsyBio Therapeutics?
O EPS de PsyBio Therapeutics Corp. é -0.12
Qual é a definição de EPS?
O lucro por ação (EPS) é a parcela do lucro de uma empresa alocada a cada ação ordinária em circulação. É ajustado para diluição e calculado ao longo de doze meses.
Earnings per share is the monetary value of earnings per outstanding share of common stock for a company. Preferred stock rights have precedence over common stock. Therefore, dividends on preferred shares are subtracted before calculating the EPS. When preferred shares are cumulative, annual dividends are deducted whether or not they have been declared. Dividends in arrears are not relevant when calculating EPS. The EPS is usually calculated as profit without preferred dividends divided by weighted average of common stock shares over the past twelve months.
EPS de empresas na Setor Health Care em TSXV em comparação com PsyBio Therapeutics
O que PsyBio Therapeutics faz?
PsyBio Therapeutics Corp., a biotechnology company, focuses on the research, development, and commercialization of psychedelic-inspired regulated medicines for the treatment of mental health and other disorders in the United States. The company is headquartered in Coconut Creek, Florida.
Empresas com eps semelhantes a PsyBio Therapeutics
- Trident Acquisitions tem EPS de -0.12
- Vatic Ventures tem EPS de -0.12
- Tonies Se Eo 1 tem EPS de -0.12
- BASE tem EPS de -0.12
- Hidili Industry International Development tem EPS de -0.12
- Punjab National Bank tem EPS de -0.12
- PsyBio Therapeutics tem EPS de -0.12
- Cyclopharm tem EPS de -0.11
- Medcolcanna Organics tem EPS de -0.11
- Intrasense SA tem EPS de -0.11
- Asia Cassava Resources tem EPS de -0.11
- Heliostar Metals tem EPS de -0.11
- Largo Resources tem EPS de -0.11